BridgeMD
New treatment option for Hip Fractures
Official title HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
ClinicalTrials.gov ID: NCT04743765
What this study is testing
- What it's testing
- The HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also assess secondary outcomes at 90 days after randomization: inability to independently walk 3 metres, time to first mobilization (first standing and first full weight bear), composite and individual assessment of major complications (e.g., mortality, non-fatal myocardial infarction, acute congestive heart failure, and stroke), delirium, length of stay, pain, and quality of life.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 and older
You may be able to join if
- age ≥45 years;
- diagnosis of hip fracture during working hours with a low-energy mechanism requiring surgery;
- troponin elevation ( at least one troponin measurement above the upper limit of normal occurring from the time of hip fracture to the time of...
- informed consent.
You likely can't join if
- taking a therapeutic dose of an anticoagulant for which no reversing agent is available and the anesthesiologist or surgeon believe surgery within 6...
- patients on a therapeutic vitamin K antagonist with a history of heparin induced thrombocytopenia (HIT);
- patients with peri-prosthetic fracture, open fracture or bilateral fractures;
- patients requiring an emergency surgery for another reason (e.g., subdural hematoma);
- patients with acute myocardial infarction deemed to be clinically unstable, with a mechanical complication (i.e., acute papillary muscle rupture...
- patients refusing consent; or
See the full eligibility criteria
- age ≥45 years;
- diagnosis of hip fracture during working hours with a low-energy mechanism requiring surgery;
- troponin elevation ( at least one troponin measurement above the upper limit of normal occurring from the time of hip fracture to the time of randomization); and
- informed consent.
- taking a therapeutic dose of an anticoagulant for which no reversing agent is available and the anesthesiologist or surgeon believe surgery within 6 hours of eligibility criteria met would not be safe;
- patients on a therapeutic vitamin K antagonist with a history of heparin induced thrombocytopenia (HIT);
- patients with peri-prosthetic fracture, open fracture or bilateral fractures;
- patients requiring an emergency surgery for another reason (e.g., subdural hematoma);
- patients with acute myocardial infarction deemed to be clinically unstable, with a mechanical complication (i.e., acute papillary muscle rupture, ventricular septal defect), ST elevation myocardial infarction, or...
- patients refusing consent; or
- patients previously enrolled in HIP ATTACK-2.
The study team makes the final eligibility decision.
Where it's taking place
- Chandler, Arizona, United States
- Davis, California, United States
- New Haven, Connecticut, United States
- Atlanta, Georgia, United States
- Baltimore, Maryland, United States
- Boston, Massachusetts, United States
- Burlington, Massachusetts, United States
- Ann Arbor, Michigan, United States
- Rochester, Minnesota, United States
- Lincoln, Nebraska, United States
- Las Vegas, Nevada, United States
- Lebanon, New Hampshire, United States
- The Bronx, New York, United States
- Cleveland, Ohio, United States
- Portland, Oregon, United States
- Bethlehem, Pennsylvania, United States
- Houston, Texas, United States
- Madison, Wisconsin, United States
- New Lambton Heights, New South Wales, Australia
- Woluwe-Saint-Lambert, Brussels Capital, Belgium
+ 41 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Chandler, Arizona, United States; Davis, California, United States; New Haven, Connecticut, United States; Atlanta, Georgia, United States; Baltimore, Maryland, United States; Boston, Massachusetts, United States and 55 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.